News

Certificate of Financial Statement - changes to the template

Published on | 1 month ago

Programmes HorizonEU L+F

The Certificate of Financial Statement (CFS) template has been adapted on 1 March 2025, with specific changes to the checklist, as explained on the last page of this document. General information about CFS is explained in our infosheet

The European Liaison Office of the German Research Organisations based in Brussels (KOWI) has gathered in November 2024 internal auditors of German universities and research institutions, the ones responsible for a.o. the issuing of the CFS. Together with two auditors from the European Court of Auditors and the ERC Executive Agency, they discussed the challenges they see for the first audits in Horizon Europe, in general and specific points of the CFS (former template). The report of this discussion can be found here

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1581 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.